Rebirth 08: Rise from copycat phones

Chapter 545 The Shock of the Super-Rich: Project ARE78
Starting in October, Galaxy Pharmaceuticals launched the first phase of clinical trials for its HT197 drug, a neuroimmunobiological agent. The clinical trial results were excellent, and it demonstrated very good symptom relief and preventative effects in indications such as the common cold.

Most importantly, after numerous improvements and secrecy, this drug actually has few side effects and is very safe.

Therefore, the clinical trial went very smoothly.

The clinical trials aren't even over yet, and many people in the medical field, especially doctors and nurses, already know about this drug... Of course, what they value isn't the drug's therapeutic effect, since it doesn't actually cure diseases.

What I value is its ability to boost immunity and prevent everyday bacteria and viruses!
Because medical personnel are a group that comes into frequent contact with bacteria and viruses in their daily work... especially internists and nurses in outpatient clinics, who come into contact with various cold patients most often.

With frequent contact, even with routine protective measures like wearing medical masks and gloves, indoor ventilation, and daily disinfection, it's inevitable to see ghosts if you walk on the dark too often... Doctors are frequently exposed to bacteria and viruses, so naturally, they have a higher chance of catching a common cold.

Now, a drug is circulating in the medical community that can effectively boost immunity and help people better prevent bacterial and viral infections.

This naturally attracted the attention of the medical community.

Especially during clinical trials, this neuroimmunobiological drug has never shown any side effects.

This medicine can even be eaten in large quantities like candy... without worrying about overdosing and causing any problems.

The drug's high efficacy in boosting immunity and lack of side effects first circulated within a small circle of medical professionals, and then spread widely within the medical community.

Before long, related information appeared online!
After all, this is not a very secretive drug that needs to be kept confidential. Galaxy Pharmaceuticals even announced it on its official website before conducting the clinical trials, which attracted some attention within the pharmaceutical industry at the time, but not much attention from the general public.

Now, more and more ordinary people are also starting to pay attention to the news about HT197, a neuroimmunobiological agent!
After all, everyone wants to be healthier and have a stronger immune system!

Especially for some parents of children... When they hear that this medicine can effectively prevent all kinds of common colds, and has no side effects, and even tastes sweet and can be eaten like candy, their mouths water just hearing about it!
I want it so much!

Because the children in my family catch colds several times a year, especially those in kindergarten and primary school, whose bodies are not yet fully developed and whose immunity is relatively weak, making them more susceptible to everyday bacterial and viral infections.

In addition, when children gather together, it is easy to cause a cluster infection... If one child catches a cold, it won't be long before many other children in the class catch a cold as well.

If there were a medicine that could boost a child's immunity and better prevent colds... well, if that medicine were safe enough, many parents would really want it.

When a child catches a cold, it's not just the child who suffers... the parents suffer too!
Taking care of a child with a cold and fever is no easy task!

Therefore, many ordinary people, especially parents of children, have begun to pay attention to the following question: What exactly is this neuroimmunological drug? Is it effective? Is it safe? Is it absolutely safe?
Many bloggers who have deep expertise in the pharmaceutical industry have also provided answers when reporting on the matter.

On a video website, a medical blogger conducted an in-depth analysis of the neuroimmunotherapy drug HT197!
"Recently, a new drug called 'Neuro-enhancing Immunotherapy' has been quite popular in the medical industry. Many ordinary people don't know much about this drug, so today I'm going to give you a thorough introduction so that you can know what this very mysterious new drug is, what it does, and why it has caused such a sensation in the medical community!"

"First of all, the box of medicine in this photo is a very popular neuro-immunostimulant biological agent, also known as a neuroimmunotherapy drug. It is an immune enhancer developed by Galaxy Pharmaceutical, a major pharmaceutical company in my country."

According to Galaxy Pharmaceutical's publicly available description and its drug information leaflet, this drug is a genetically engineered biological macromolecule that can significantly enhance the immune system's capabilities through the nervous system!

"Its technical approach is completely different from that of some existing immune enhancers such as thymopeptide and pidotimod."

"And its usage is also quite different from these traditional prescription immune-boosting drugs. It is somewhat similar to vitamin C, vitamin D, and zinc supplements, but its effects are far better than traditional prescription immune-boosting drugs and even better than nutritional supplements!"

"It is worth noting that the drug has not yet been officially approved for marketing and is still in the clinical trial stage. Therefore, the box of medicine in my hand is not a marketed product, but a clinical trial-specific one. A friend of mine happened to participate in the clinical trial of this drug, so I was fortunate enough to take the picture."

"Therefore, this drug is not currently available on the market. Recently, some illegal individuals have been disguising starch tablets as neuroimmune drugs for private sale; some unscrupulous merchants are also using terms like 'neuroimmune' on health products for false advertising. Please be careful to distinguish between genuine and fake products!"

"Currently, neuroimmunotherapy drugs are still in the clinical trial stage. Galaxy Pharmaceutical has only produced small batches of dedicated clinical drugs for use in clinical trials. Moreover, these clinical trial drugs are all strictly controlled and cannot be sold on the market!"

"So now, if anyone tells you they have any Galaxy Neuroimmune Drugs, report them to the police immediately, because they're most likely selling fake drugs!"

"It's one thing if they make these fake medicines with starch tablets, but I'm afraid these fake medicine sellers will put in some random stuff. Who knows what the consequences will be if you take them!"

"The manufacturer of this neuroimmunotherapy drug is Galaxy Pharmaceuticals. You should be familiar with Galaxy Pharmaceuticals. That's right, it's the world's number one pharmaceutical company, the one that developed and produced Xelocta, a broad-spectrum anti-cancer drug!"

"Although this company is not a publicly listed company and doesn't release much information to the public, and even its official website is very rudimentary, this company is remarkable. Last year, its revenue reached at least 70 billion US dollars... This is not my opinion, nor is it even said by a Chinese person. It is from a global pharmaceutical industry report given by an American statistical analysis agency!"

"The company's Xeloda is a global bestseller, generating six to seven hundred billion US dollars in revenue annually. In addition to Xeloda, the company also has more than twenty other drugs on the market. Although most of them are generic drugs, the quality is very good. In particular, their tenofovir is a drug used for hepatitis. The generic version from Galaxy Pharma is no less effective than the original drug, but it is more expensive than other similar generic drugs!"

"This company also has a business in medical equipment and consumables, which ordinary people may not know, but their MRI machines are quite good."

Galaxy Pharmaceutical's 1.5T and 3T MRI scanners have rapidly climbed to second place globally in terms of shipments this year, capturing a significant share of the domestic market and also exporting a considerable amount, with their market share continuing to rise rapidly!

"I'm saying all this just to say that Galaxy Pharmaceuticals is not some second- or third-rate, low-quality manufacturer. Don't compare it to some of the messy, low-quality pharmaceutical companies in China, and don't treat its original drugs as common, mass-produced goods!"

"Neuroimmunotherapy is Galaxy Pharmaceutical's latest original drug, and it is also a very advanced biological macromolecule original drug. In the field of enhancing immunity, its current effect far exceeds that of traditional immune-enhancing drugs!"

"At least that's what the current clinical trials show!"

"Moreover, I have not heard of any side effects from this drug. Not only are there no obvious side effects, but there are not even any mild side effects."

"In current clinical trials, as far as I know, it is mainly used in conjunction with the treatment of common colds. However, as an immune-enhancing drug, it can also be used to combat recurrent bacterial infections, for postoperative recovery, or for other indications of low immune indicators. Moreover, its expected efficacy will far exceed that of traditional immune-enhancing drugs."

"Furthermore, many professionals in the medical field have higher expectations for the application of this drug, such as its use in the prevention of infectious diseases and the prevention of common colds!"

"This is one of the reasons why many medical professionals are paying close attention to this drug. After all, doctors are frequently exposed to bacteria and viruses, and they have a greater need than ordinary people for this kind of immune-boosting drug with few side effects for daily prevention!"

"Finally, I would like to reveal that the core of the treatment process for AIDS patients is to restore and enhance their immunity in order to avoid repeated infections."

"Therefore, this neuroimmunotherapy drug has the potential to become part of the daily medication regimen for HIV patients, working in conjunction with other drugs to enhance their immunity... Of course, this is only a possibility, and further clinical trials and exploration by the medical community are needed to determine the specifics!"

"However, the emergence of such an immune-boosting drug undoubtedly brings us more possibilities for treating and preventing diseases, and its significance is still very important!"

------

The information revealed by professional bloggers has enabled many ordinary people to understand the background and effects of this Galaxy neuroimmunotherapy drug.

This has also drawn more attention to the drug... especially since it has no side effects, can be eaten like candy, and has been approved as an over-the-counter drug.

You don't need a doctor's prescription for this; you can just buy it from the pharmacy and take it yourself!

Many people are also concerned about the price of this drug, but Galaxy Pharmaceuticals has not yet disclosed any information about the research and development costs or the possible selling price.

However, considering the indications and daily prevention, this medicine won't be too expensive... It's just a common cold. You can't expect patients to spend thousands or tens of thousands of dollars to buy an immune-boosting drug. That's impossible. People would rather endure it for a few days or simply use vitamin C instead!

Forget thousands or tens of thousands, even a few hundred yuan would be a stretch...

According to the anticipated plan discussed internally by Galaxy Pharmaceuticals, considering that the main indication for this drug is to assist in the treatment and prevention of common bacterial or viral infections.

The main scenarios for this type of illness are actually the common cold, as well as recovery from injury or surgery to enhance immunity.

At the same time, considering the huge potential market for common cold medicines, this medicine will be priced affordably to expand market share as much as possible!
I estimate that the price in China will be around 100 yuan if it's one pill a day, or six pills a box... because only at that price can most people afford to buy and consume it!

Medicines that are unaffordable have no sales and are therefore worthless!

If everyone can afford it, sales will increase, and revenue will increase!
The potential market for popular medications used in conjunction with treatments and prevention of bacterial or viral infections is enormous!
With such a huge global population, countless people catch colds every day, and countless others need to boost their immunity to prevent infection due to injuries or surgeries. The potential market is enormous!

Of course, while neuroimmunotherapy drugs are quite good and effective, as a combination therapy and infection prevention medication, they are not irreplaceable. Therefore, their total sales are limited and cannot be compared with the market share of broad-spectrum anticancer drugs like Xelocta!
In the pharmaceutical market, Xelocta has been one of the hottest products in recent years!

It has a huge reputation among medical professionals and cancer patients, and even many ordinary people know about this miracle anti-cancer drug because its efficacy is simply too exaggerated!
This is currently the only broad-spectrum anti-cancer drug in human history, and its efficacy is outstanding... Early-stage patients within the indications can basically be cured within one or two courses of treatment, without the need for surgery!
Patients in the middle stage require a longer treatment course, but most can still achieve very good results.

Even patients in the late stages can achieve very good results with this drug.

To date, Xeloda has been shown to be highly effective against more than 27 types of cancer through numerous clinical trials, and has saved the lives of countless cancer patients in the past few years!

In fact, many other cancer patients who have not been diagnosed with this drug also use it, because it can be effective for some non-indication cancers. Although the effect is not very good, it is better than nothing!
This is why Hilokta's annual sales are so staggering... it's just so incredibly useful.

Even though the prices are high, with single treatment courses costing tens of thousands of US dollars under health insurance in different parts of the world, the differences are not significant. They mainly depend on local medical institutions, tariffs, operating costs, and negotiations with local health insurance institutions or companies.

As for drug prices, Galaxy Pharmaceuticals determines the wholesale price. As for the price at the end market, there are many other determining factors. For example, if Galaxy Pharmaceuticals sells a drug to a hospital in a certain country for $20,000, there will be tariff costs, operating costs, and the hospital's own costs and profits in between. The final price that the patient receives will be significantly different.

Despite its high price, the drug still sells incredibly well.

Currently, Xeloda is available in major pharmaceutical markets around the world through both official and commercial health insurance systems.

Even for many commercial health insurance policies, whether or not they offer high reimbursement rates for Xeloda has become a selling point and a competitive advantage...

The reason why many health insurance systems choose to include Xelocta in their coverage is not because they are kind-hearted... but because it is cheaper to do so!
For patients who have purchased commercial medical insurance, getting a cancer diagnosis certainly doesn't mean they just wait to die; they will seek various treatments.

Various anti-cancer chemotherapy, surgery, targeted drugs and other treatments are being used in turn... and all of this is being spent on insurance company money.

Now Galaxy Pharmaceuticals offers insurance companies a new option: with my Xelocta, you can significantly reduce your company's premium expenses in the field of cancer!
Of course, the main reason is that many insurance customers demand reimbursement for Xeloda, otherwise they will not purchase commercial medical insurance from this insurance company.

If you don't even reimburse Hilokta, it means your insurance company is incompetent...

The powerful efficacy of Xeloda has directly led to its gradual entry into markets around the world and its widespread adoption in local and commercial health insurance systems!

Throughout this period, Galaxy Pharmaceuticals did not even conduct any large-scale advertising or promotion... it basically accepted everything passively!
My medicine is right here, buy it or not, it's up to you...

Whichever country needs it can just import it themselves.

If they think the drug is too expensive, then they can simply include it in their own medical insurance programs.

In this process, Galaxy Pharmaceuticals is at most cooperating by submitting some clinical trial reports from various major countries or regions and applying for local marketing authorizations—it's just a formality!
If it's a country with a decent market size, Galaxy Pharmaceuticals will symbolically conduct a clinical trial there, recruiting a few dozen volunteers to conduct a so-called clinical trial and that's it.

After all, Xeloda has already obtained approval and marketing authorization from major pharmaceutical markets such as China, the United States, the European Union, and Japan. Other countries can simply refer to the clinical trial results of these countries and then quickly approve its market launch.

Don't tell the people at Galaxy Pharmaceuticals that our country's drug regulations are stricter than those of the aforementioned major countries or regions... You must follow my standards.

If the other party wants Galaxy Pharmaceuticals to enter the market and then tries to negotiate a lower price and create various obstacles, Galaxy Pharmaceuticals will say: Dear customer, my Xeloda production capacity is limited, and it is already in short supply. How about we talk about entering your market again in a few years?

In short, it's take it or leave it!
People in the medical and health insurance industries in many countries feel that Galaxy Pharmaceuticals is too arrogant... especially in price negotiations, where they are very strict and it is very difficult to get them to lower their prices.

But is it okay not to buy it?
Can not be done!
A large number of their insurance clients are waiting for this drug to save their lives after being diagnosed with cancer... Their insurance company is also waiting for this drug to significantly reduce the premiums paid by their clients after being diagnosed with cancer.

The customer is waiting for a life-saving treatment, and the insurance company needs to reduce premium expenses to make more money!

This collectively contributed to the global success of Xelocta!

Xeloda is special; Galaxy Pharmaceuticals topped the list of global pharmaceutical companies in terms of both revenue and profit with just this one drug.

In just a few years, it became the world's number one pharmaceutical company!

Of course, this claim of being number one in the world is rather unsubstantiated, as it is entirely supported by the drug Xeloda. The company is quite poor in terms of other pharmaceuticals and medical equipment.

In recent years, Galaxy Pharmaceutical has been trying its best to develop and produce some conventional generic drugs and some conventional original drugs, but the progress has not been very significant. The conventional drug market is already very crowded. In addition, Galaxy Pharmaceutical is unwilling to produce low-priced and inferior drugs in the field of generic drugs, so it is very difficult to enter the medical insurance system.

They can only sell through self-funded retail channels, resulting in relatively limited sales volume.

However, some companies have done quite well. After their patents expired, high-quality generic drugs with relatively high technical requirements have successfully entered the medical insurance markets of various countries.

In the field of medical equipment and consumables, there are conventional medical equipment and consumables, but the time frame is relatively short and the quality is generally average.

However, it has done very well in the field of nuclear magnetic resonance equipment. Through acquisitions and its own research and development, the two mainstream nuclear magnetic resonance equipment, 1.5T and 3T, have sold very well in China and have also begun to be exported in batches. It is a relatively bright business of Galaxy Pharmaceutical.

The main advantage lies in the superconducting materials of the Zhiyun Group. The Zhiyun Group's KT120 superconducting material is an excellent, low-cost superconducting material that is quite useful in the field of nuclear magnetic resonance.

Another area where they have performed exceptionally well is in the field of artificial intelligence in healthcare. The AI-assisted diagnostic model developed by Galaxy Pharmaceutical has already been applied in some partner hospitals and has shown great potential.

As a professional medical assistance system designed for doctors, this Galaxy Medical Assisted Diagnosis Model is exceptionally well-made!
This system is also known as a prime example of the medical field embracing artificial intelligence!

In other words, Galaxy Pharmaceuticals is not listed on the stock market. Otherwise, this one medical auxiliary diagnostic system alone could have increased its market value by hundreds of billions of dollars!
This market is huge... How many hospitals and doctors are there in the world? They are all users with a strong demand for this system, and the price of such a professional system is not cheap, which means that the revenue will be very high.

Artificial intelligence has already begun to penetrate and be applied on a large scale in the medical field... Of course, the average person is not yet feeling it deeply... After all, Galaxy Pharmaceuticals has not opened this medical auxiliary diagnostic system to the general public!
Because this system is highly specialized, it requires various professional data, including examination reports and doctors' subjective observations, before it can provide feedback!
Ordinary people can't use it properly, and blind use may even bring some medical risks!
In recent years, Galaxy Pharma has rapidly expanded into other medical business areas by relying on Xeloda, its cash cow, mainly through acquisitions combined with its own research and development.

Currently, we are involved in the fields of conventional chemical drugs, biological drugs, including generic drugs, as well as conventional medical equipment and consumables.

Of course, most of these businesses were actually acquired first. Last year alone, Galaxy Pharmaceuticals spent more than eight billion US dollars to acquire multiple pharmaceutical companies around the world to integrate resources and enrich its own business product line.

Today, Galaxy Pharmaceuticals has rapidly grown into a veritable global pharmaceutical giant, with revenues exceeding $70 billion last year, and it is expected to reach new heights this year!
Next year, barring any unforeseen circumstances, neuroimmunotherapy drugs will be launched in China first, and then gradually undergo clinical trials in other countries before being launched on the market. This will bring new business growth points to Galaxy Pharmaceutical.

Perhaps in just a few years, Galaxy Pharmaceuticals' annual revenue will be approaching 100 billion US dollars!

Outsiders, many ordinary people are unaware that such a pharmaceutical giant has emerged in China... The main reason is that the pharmaceutical industry is somewhat distant from ordinary people, unlike the smart terminal industry, or even virtual devices, robots, and cars, which people come into contact with daily and are covered in news about.

There is much less news about Galaxy Pharmaceutical, especially since Galaxy Pharmaceutical is relatively low-key and doesn't do much advertising.

Therefore, in the eyes of ordinary people, Galaxy Pharmaceuticals has little presence!

However, within the healthcare industry, the influence of such a pharmaceutical giant aiming for hundreds of billions of dollars in revenue is enormous!

Putting aside everything else, Galaxy Pharmaceutical's various acquisitions each year are enough to impact the ecosystem of the pharmaceutical industry.

However, even such a giant pharmaceutical company with hundreds of billions in assets is not considered an important enterprise in Xu Shenxue's business empire... The company's positioning has always been very clear: it is just a front for Galaxy Life to put on the surface!

A small group of super-rich people on Earth actually know about this... After all, many of them are benefactors of Galactic Life... They only ask for money and not shares, but the right to use future anti-aging and life-extending drugs or technologies!
But they gave it to them willingly!
And so, after spending countless funds, Galactic Life has finally brought a return to these donors: Project ARE78 has achieved initial success!

The hope of extending lifespan is not yet in sight... but the hope of anti-aging and regaining youth has already been seen!

A small number of elderly super-rich individuals have even eagerly participated in the Phase IV clinical trials and started taking the ARE78 drug.

After a few of the super-rich individuals who participated in the experiment took the ARE78 drug for a period of time, other super-rich individuals also saw the effects on them: Is it really that amazing?
The old man who used to be frail and unable to walk can now walk on his own without anyone's help?

Then, even more super-rich people became interested and began to inquire about the usage of the ARE78 project after it was officially opened, such as the price!
(End of this chapter)